Beyond Air Inc

XAIR | Healthcare | NASDAQ
$2.43
-0.07 (-2.80%)

Key Metrics

Market Cap
$12.70M
P/E Ratio
-0.24
EPS
$-10.01
Beta
N/A
Dividend Yield
N/A
ROE
-243.16%
Current Ratio
3.24

Company Information

Industry
Medical Devices

About Beyond Air Inc

Beyond Air Inc operates as a commercial medical device and biopharmaceutical company The company engages in the development of LungFit platform a nitric oxide generator and delivery system It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn The company is also developing LungFit PRO for the treatment of viral lung infections such as communityacquired viral pneumonia including COVID19 as well as bronchiolitis in hospitalized patients and LungFit GO for the treatment of nontuberculous mycobacteria The company was formerly known as AIT Therapeutics Inc and changed its name to Beyond Air Inc in June 2019 Beyond Air Inc is based in Garden City New York

Recent Earnings Surprises

Date Actual EPS Estimated EPS Surprise
2025-08-12 $-1.53 $-1.50 2.0%
2025-06-17 $-1.80 $-2.80 +-35.7%
2025-02-10 $-0.15 $-0.24 +-37.5%
2024-11-11 $-0.28 $-0.30 +-6.7%

Financial Ratios (TTM)

Gross Margin
-24.57%
Operating Margin
-806.69%
Net Margin
-880.70%
ROA
-149.80%
Price to Book
1.23
Price to Sales
2.65